Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The study will determine the efficacy of twice weekly hemodialysis in patients with residual kidney function.
Full description
Hemodialysis patients who have residual kidney function will undergo two 4-week study (twice weekly versus thrice weekly hemodialysis) using a cross-over design. Blood, urine, and dialysate samples will be collected at the end of each study period to determine adequacy of treatment and to assess uremic solute levels. Participants will complete quality of life questionnaires and cognitive paper tests.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
58 participants in 2 patient groups
Loading...
Central trial contact
Saniya Bonde, BS; Tammy Sirich, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal